Single-dose therapy of gonococcal ophthalmia neonatorum with ceftriaxone
View/ Open
Date
1986Author
Laga, M
Naamara, W
Brunham, RC
D'Costa, LJ
Nsanze, H
Piot, P
Kunimoto, D
Ndinya-Achola Jeckoniah O.
Slaney, L
Ronald, AR
Type
ArticleLanguage
enMetadata
Show full item recordAbstract
We conducted a randomized clinical trial comparing a single intramuscular dose of 125 mg of ceftriaxone with a single intramuscular dose of 75 mg of kanamycin followed by topical gentamicin for seven days, and with a single intramuscular dose of 75 mg of kanamycin followed by topical tetracycline for seven days, in the treatment of gonococcal ophthalmia neonatorum in Nairobi, Kenya. Of 122 newborns with culture-proved gonococcal ophthalmia neonatorum, 105 returned for follow-up. Sixty-one infants (54 percent) received ceftriaxone, 32 received kanamycin plus topical gentamicin, and 29 received kanamycin plus topical tetracycline. Sixty-six (54 percent) of the Neisseria gonorrhoeae isolates were penicillinase producing. All 55 newborns who received ceftriaxone and returned for follow-up were clinically and microbiologically cured. One of 26 returning newborns who received kanamycin plus tetracycline and 2 of 24 returning newborns who received kanamycin plus gentamicin had persistent or recurrent gonococcal conjunctivitis. Ceftriaxone also eradicated oropharyngeal gonococcal infection in 18 newborns, whereas oropharyngeal infection persisted in 2 of 8 newborns who had received kanamycin (P not significant). We conclude that 125 mg of ceftriaxone as a single intramuscular dose is very effective therapy for gonococcal ophthalmia neonatorum, with marked efficacy against extraocular infection and without the need for concomitant topical antimicrobial therapy.
URI
http://www.ncbi.nlm.nih.gov/pubmed/3095641http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/17146
Citation
N Engl J Med. 1986 Nov 27;315(22):1382-5Publisher
Department of Medical Microbiology, University of Nairobi
Collections
- Faculty of Health Sciences (FHS) [10377]